Imaging Microglial/Macrophage Activation in Spinal Cords of Experimental Autoimmune Encephalomyelitis Rats by Positron Emission Tomography Using the Mitochondrial 18 kDa Translocator Protein Radioligand [18F]DPA-714

Multiple sclerosis (MS) is an inflammatory demyelinating disease of the CNS. Activated microglia/macrophages play a key role in the immunopathogenesis of MS and its corresponding animal models, experimental autoimmune encephalomyelitis (EAE). Microglia activation begins at early stages of the disease and is associated with elevated expression of the 18 kDa mitochondrial translocator protein (TSPO). Thus, positron emission tomography (PET) imaging of microglial activation using TSPO-specific radioligands could be valuable for monitoring disease-associated neuroinflammatory processes. EAE was induced in rats using a fragment of myelin basic protein, yielding acute clinical disease that reflects extensive spinal cord inflammation. Enhanced TSPO expression in spinal cords of EAE rats versus those of controls was confirmed by Western blot and immunohistochemistry. Biodistribution studies in control and EAE rats were performed using the TSPO radioligand [18F]DPA-714 [N,N-diethyl-2-(2-(4-(2-fluoroethoxy)phenyl)-5,7-dimethylpyrazolo[1,5-a]pyrimidin-3-yl)acetamide]. At 1 h after injection, almost fivefold higher levels of [18F]DPA-714 were measured in spinal cords of EAE rats versus controls. The specific binding of [18F]DPA-714 to TSPO in spinal cords was confirmed in competition studies, using unlabeled (R,S)-PK11195 [(R,S)-N-methyl-N-(1-methylpropyl)-1-(2-chlorophenyl)isoquinoline-3-carboxamide)] or DPA-714 in excess. MicroPET studies affirm that this differential radioactivity uptake in spinal cords of EAE versus control rats could be detected and quantified. Using [18F]DPA-714, neuroinflammation in spinal cords of EAE-induced rats could be visualized by PET, offering a sensitive technique for monitoring neuroinflammatory lesions in the CNS and particularly in the spinal cord. In addition to current MRI protocols, this approach could provide molecular images of neuroinflammation for detection, monitoring, and research in MS.

[1]  F. Dollé,et al.  [18F]DPA-714, [18F]PBR111 and [18F]FEDAA1106-selective radioligands for imaging TSPO 18 kDa with PET: automated radiosynthesis on a TRACERLAb FX-FN synthesizer and quality controls. , 2012, Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine.

[2]  Richard B. Banati,et al.  Positron emission tomography imaging of neuroinflammation , 2007, Neurotherapeutics.

[3]  R. Boisgard,et al.  Radioisotopic Imaging of Neuroinflammation , 2010, Journal of Nuclear Medicine.

[4]  Annelaure Damont,et al.  Evaluation of the PBR/TSPO Radioligand [18F]DPA-714 in a Rat Model of Focal Cerebral Ischemia , 2010, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[5]  Michael Kassiou,et al.  Radiolabelled molecules for imaging the translocator protein (18 kDa) using positron emission tomography. , 2009, Current medicinal chemistry.

[6]  David H. Miller,et al.  Imaging outcomes for neuroprotection and repair in multiple sclerosis trials , 2009, Nature Reviews Neurology.

[7]  Annelaure Damont,et al.  Comparative Evaluation of the Translocator Protein Radioligands 11C-DPA-713, 18F-DPA-714, and 11C-PK11195 in a Rat Model of Acute Neuroinflammation , 2009, Journal of Nuclear Medicine.

[8]  Makoto Sawada,et al.  Imaging of Peripheral Benzodiazepine Receptor Expression as Biomarkers of Detrimental versus Beneficial Glial Responses in Mouse Models of Alzheimer's and Other CNS Pathologies , 2008, The Journal of Neuroscience.

[9]  B. Tavitian,et al.  Radiosynthesis of [18F]PBR111, a selective radioligand for imaging the translocator protein (18 kDa) with PET , 2008 .

[10]  H. Weiner,et al.  Novel therapeutic strategies for multiple sclerosis — a multifaceted adversary , 2008, Nature Reviews Drug Discovery.

[11]  C. Stadelmann,et al.  From fish to man: understanding endogenous remyelination in central nervous system demyelinating diseases , 2008, Brain : a journal of neurology.

[12]  Denis Guilloteau,et al.  DPA-714, a New Translocator Protein–Specific Ligand: Synthesis, Radiofluorination, and Pharmacologic Characterization , 2008, Journal of Nuclear Medicine.

[13]  Frederik Barkhof,et al.  Pluriformity of inflammation in multiple sclerosis shown by ultra-small iron oxide particle enhancement. , 2008, Brain : a journal of neurology.

[14]  W. Brück,et al.  Interplay between mechanisms of damage and repair in multiple sclerosis , 2008, Journal of Neurology.

[15]  R. Reynolds,et al.  Normal-appearing white matter in multiple sclerosis is in a subtle balance between inflammation and neuroprotection. , 2007, Brain : a journal of neurology.

[16]  K. Mardon,et al.  Pharmacological evaluation of [123I]-CLINDE: a radioiodinated imidazopyridine-3-acetamide for the study of peripheral benzodiazepine binding sites (PBBS) , 2008, European Journal of Nuclear Medicine and Molecular Imaging.

[17]  O. Ciccarelli,et al.  Spinal cord spectroscopy and diffusion-based tractography to assess acute disability in multiple sclerosis. , 2007, Brain : a journal of neurology.

[18]  M. Filippi,et al.  In vivo assessment of cervical cord damage in MS patients: a longitudinal diffusion tensor MRI study. , 2007, Brain : a journal of neurology.

[19]  J. Keyser,et al.  Janus faces of microglia in multiple sclerosis , 2007, Brain Research Reviews.

[20]  H. Atkins,et al.  Autologous haematopoietic stem cell transplantation fails to stop demyelination and neurodegeneration in multiple sclerosis. , 2007, Brain : a journal of neurology.

[21]  M. Phelps,et al.  Positron emission tomography with computed tomography imaging of neuroinflammation in experimental autoimmune encephalomyelitis , 2007, Proceedings of the National Academy of Sciences.

[22]  Hans Lassmann,et al.  Widespread Demyelination in the Cerebellar Cortex in Multiple Sclerosis , 2007, Brain pathology.

[23]  Hans Lassmann,et al.  Understanding pathogenesis and therapy of multiple sclerosis via animal models: 70 years of merits and culprits in experimental autoimmune encephalomyelitis research. , 2006, Brain : a journal of neurology.

[24]  W. Klunk,et al.  Imaging of CNS myelin by positron-emission tomography. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[25]  J. Caillé,et al.  MR imaging of relapsing multiple sclerosis patients using ultra-small-particle iron oxide and compared with gadolinium. , 2006, AJNR. American journal of neuroradiology.

[26]  Hans Lassmann,et al.  Cortical demyelination and diffuse white matter injury in multiple sclerosis. , 2005, Brain : a journal of neurology.

[27]  F. Mattner,et al.  Evaluation of a radiolabelled peripheral benzodiazepine receptor ligand in the central nervous system inflammation of experimental autoimmune encephalomyelitis: a possible probe for imaging multiple sclerosis , 2005, European Journal of Nuclear Medicine and Molecular Imaging.

[28]  R. Banati,et al.  Brain microglia and blood-derived macrophages: molecular profiles and functional roles in multiple sclerosis and animal models of autoimmune demyelinating disease , 2004, Brain Research Reviews.

[29]  U. Bogdahn,et al.  High-resolution MR imaging of the rat spinal cord in vivo in a wide-bore magnet at 17.6 Tesla , 2004, Magnetic Resonance Materials in Physics, Biology and Medicine.

[30]  M. Cheeran,et al.  Role of Microglia in Central Nervous System Infections , 2004, Clinical Microbiology Reviews.

[31]  K. Nicolay,et al.  Blood-brain barrier permeability and monocyte infiltration in experimental allergic encephalomyelitis: a quantitative MRI study. , 2004, Brain : a journal of neurology.

[32]  D. Mann,et al.  The neuropathology of frontotemporal lobar degeneration with respect to the cytological and biochemical characteristics of tau protein , 2004, Neuropathology and applied neurobiology.

[33]  F. Barkhof,et al.  Spinal cord abnormalities in recently diagnosed MS patients , 2004, Neurology.

[34]  F. Turkheimer,et al.  Translating the cellular neuropathology of microglia into neuroimaging results , 2004 .

[35]  R. Banati,et al.  Neuropathological imaging: in vivo detection of glial activation as a measure of disease and adaptive change in the brain. , 2003, British medical bulletin.

[36]  R. Liblau,et al.  LF 15-0195 Inhibits the Development of Rat Central Nervous System Autoimmunity by Inducing Long-Lasting Tolerance in Autoreactive CD4 T Cells 1 , 2003, The Journal of Immunology.

[37]  R. Banati,et al.  Visualising microglial activation in vivo , 2002, Glia.

[38]  A. Minagar,et al.  The role of macrophage/microglia and astrocytes in the pathogenesis of three neurologic disorders: HIV-associated dementia, Alzheimer disease, and multiple sclerosis , 2002, Journal of the Neurological Sciences.

[39]  Peter T. Nelson,et al.  Microglia in diseases of the central nervous system , 2002, Annals of medicine.

[40]  H. Benali,et al.  BrainVISA: Software platform for visualization and analysis of multi-modality brain data , 2001, NeuroImage.

[41]  R B Banati,et al.  The peripheral benzodiazepine binding site in the brain in multiple sclerosis: quantitative in vivo imaging of microglia as a measure of disease activity. , 2000, Brain : a journal of neurology.

[42]  G. Kreutzberg Microglia: a sensor for pathological events in the CNS , 1996, Trends in Neurosciences.

[43]  Hans Lassmann,et al.  Monocyte/macrophage differentiation in early multiple sclerosis lesions , 1995, Annals of neurology.

[44]  R. Swanborg,et al.  A comparative study of experimental autoimmune encephalomyelitis in Lewis and DA rats. , 1995, Journal of immunology.

[45]  R. Anholt,et al.  Peripheral-type benzodiazepine receptors: autoradiographic localization in whole-body sections of neonatal rats. , 1985, The Journal of pharmacology and experimental therapeutics.

[46]  M. Kirschner,et al.  Peptide mapping by limited proteolysis in sodium dodecyl sulfate and analysis by gel electrophoresis. , 1977, The Journal of biological chemistry.

[47]  M. M. Bradford A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. , 1976, Analytical biochemistry.